Literature DB >> 22006875

Effect of sex on symptoms associated with gastroesophageal reflux.

Zhen Chen1, Sarah K Thompson, Glyn G Jamieson, Peter G Devitt, David I Watson.   

Abstract

BACKGROUND: Previous research suggests that females have a poorer outcome than do males after surgery for gastroesophageal reflux.
OBJECTIVE: To evaluate reflux and esophageal symptoms in males and females in a community sample and in patients undergoing antireflux surgery.
DESIGN: Face-to-face interview.
SETTING: A South Australian community. PARTICIPANTS: Random sample of 2973 individuals from the community and 2153 patients presenting for antireflux surgery. MAIN OUTCOME MEASURES: In a random sample of 2973 individuals from the community, the prevalence of reflux and other esophageal symptoms was determined and compared with symptoms in 2153 patients presenting for antireflux surgery. Identical questions were used to assess frequency and severity of heartburn and dysphagia and medication use. Analog scales assessed heartburn and dysphagia (0 indicating no symptoms and 10, severe symptoms). Outcomes for males vs females were compared across both groups.
RESULTS: In the community, females were more likely to report heartburn, and when reported, symptom severity was higher. The prevalence of dysphagia was similar for males and females, although females reported higher dysphagia scores for solid foods. A similar proportion of males and females took antireflux medications. Females presenting for antireflux surgery were, on average, 7 years older than males, had a higher body mass index, and had higher heartburn and dysphagia symptom scores. At endoscopy, men were more likely to have ulcerative esophagitis and Barrett esophagus, and at surgery they were less likely to have a hiatal hernia.
CONCLUSIONS: Significant differences were noted between males and females in the frequency and severity of gastroesophageal reflux-associated symptoms in the community and in patients presenting for surgery. These might reflect differences in symptom perception, which explain previously reported better outcomes in men undergoing antireflux surgery.

Entities:  

Mesh:

Year:  2011        PMID: 22006875     DOI: 10.1001/archsurg.2011.248

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

Review 1.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

2.  A Novel, Dynamic Statistical Model for Predicting Patient Satisfaction with Fundoplication Based on Pre-Operative Symptom Patterns.

Authors:  B L Woodham; R Meng; R H Roberts
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

3.  Acute gastric incarceration from thoracic herniation in pregnancy following laparoscopic antireflux surgery.

Authors:  Louise Brygger; Claus Wilki Fristrup; Frederik Severin Gråe Harbo; Jan Stener Jørgensen
Journal:  BMJ Case Rep       Date:  2013-02-01

4.  Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men.

Authors:  Chung-Hsin Chang; Cheng-Pin Wu; Jung-Der Wang; Shou-Wu Lee; Chi-Sen Chang; Hong-Zen Yeh; Chung-Wang Ko; Han-Chung Lien
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

5.  A Longitudinal, Population-Level, Big-Data Study of Helicobacter pylori-Related Disease across Western Australia.

Authors:  Michael J Wise; Binit Lamichhane; K Mary Webberley
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

6.  Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals.

Authors:  Farhad Islami; Siavosh Nasseri-Moghaddam; Akram Pourshams; Hossein Poustchi; Shahryar Semnani; Farin Kamangar; Arash Etemadi; Shahin Merat; Masoud Khoshnia; Sanford M Dawsey; Paul D Pharoah; Paul Brennan; Christian C Abnet; Paolo Boffetta; Reza Malekzadeh
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

7.  Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group.

Authors:  Juan Carlos López-Alvarenga; William Orr; José Antonio Vargas-Romero; José María Remes-Troche; Miguel Morales-Arámbula; Julio César Soto-Pérez; Gualberto Mateos-Pérez; Sergio Sobrino-Cossío; Oscar Teramoto-Matsubara; Aurelio López-Colombo; Antonio Orozco-Gamiz; Adolfo Saez-Ríos; Araceli Arellano-Plancarte; Jazmin Chiu-Ugalde; Anne Tholen; Silke Horbach; Lars Lundberg; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

8.  Prevalence and Correlates of Gastroesophageal Reflux Disease in Southern Iran: Pars Cohort Study.

Authors:  Zohre Khodamoradi; Abdullah Gandomkar; Hossein Poustchi; Alireza Salehi; Mohammad Hadi Imanieh; Arash Etemadi; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2017-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.